Applications of N,N'-(1,2-Dihydroxyethylene)Bisacrylamide in Industrial Manufacturing

As the original producer of N,N'-(1,2-Dihydroxyethylene)Bisacrylamide, we supply this specialty crosslinker directly to multiple advanced manufacturing sectors that demand stringent reproducibility and precise performance. We focus on application-led development; our technical support and QC systems address the real-world integration needs of major industrial segments adopting this material.

1. Polyacrylamide-Based Water Treatment Flocculant Production

Major municipal and industrial water treatment plants use advanced polyacrylamide flocculants crosslinked with this bisacrylamide for enhanced gel strength and resistance to hydrolysis in high-ionic-strength water. Our material ensures stable network formation under variable pH and long-term operational conditions, meeting increasing regulatory expectations for chemical safety in water clarification solutions.

Industry compliance standards

• EU REACH Regulation
• U.S. Environmental Protection Agency (EPA) – NSF/ANSI Standard 60 Certification for Drinking Water Treatment Chemicals
• China GB 5749-2022 Standards for Drinking Water Quality
• ISO 9001:2015 Quality Management System

Typical usage ratio

• 0.1%–0.5% by mass relative to monomer weight; plant engineers may reduce dosage when targeting lower residual acrylamide or modify up to 1% for ultra-high molecular weight grades.

Downstream process integration

• Batch polymerization reactors: add after monomer feed and before polymerization initiators to ensure homogeneous network formation. Vigorously monitor mixing and temperature ramp profiles for consistent gelation.

Final product types

• Granular anionic and cationic polyacrylamide flocculants
• Tablet and block flocculant systems for potable and wastewater treatment
• Polyacrylamide-based sludge dewatering agents

2. Chromatographic Media Synthesis for Bioprocessing

Biomedical supply manufacturers use our bisacrylamide to crosslink acrylamide matrices tailored for protein separation in gel filtration and polyacrylamide gel electrophoresis. Material purity and batch consistency support compliance for regulated life sciences production environments, especially where endotoxin and leachable content must be strictly controlled.

Industry compliance standards

• USP/NF Monographs (for ancillary chemical reagents)
• ISO 13485:2016 Medical Device Quality System for diagnostic media
• ICH Q7 GMP guidelines for active and inactive pharmaceutical chemicals
• OECD Good Laboratory Practice (GLP) Standards

Typical usage ratio

• 2–5% of total monomer mass in gel recipes for analytical gel electrophoresis; production-scale agarose/acrylamide beads may adjust the amount to 1–3% to customize pore size for target biomolecules.

Downstream process integration

• Dissolve acrylamide and crosslinker in buffer prior to initiation; moderate the temperature and pH to prevent premature polymerization. Monitor crosslinking kinetics using viscosity or gel turbidity to ensure lot-to-lot reproducibility.

Final product types

• PAG (polyacrylamide gel) plates and cassettes for clinical and research electrophoresis
• Packed resin columns for biomolecule purification
• Disposable gel cartridges for analyzers and diagnostic instruments

3. Oilfield Enhanced Recovery Polymer Gel Systems

Oilfield chemical service providers formulate high-stability polymer gels with our crosslinker to control water mobility or plug zones with excessive water production. These gels require strict batch performance under harsh reservoir temperatures and salinities. Our industrial process consistently supplies low-residual-content crosslinker suited to downhole regulatory and safety requirements in the petroleum sector.

Industry compliance standards

• API Q1 Quality Management System for Oil and Gas Industry
• China SY/T 6302-2016 Oilfield Chemicals Standards
• U.S. EPA Chemical Data Reporting (CDR) for environmental release risk
• SOGAT regulations (Sulphur Optimization & Gas Association Technical)

Typical usage ratio

• 0.3–1.2% by total monomer mass, with field adjustments based on brine composition, expected gelation time, and reservoir temperature (often optimized by lab-scale core flow tests).

Downstream process integration

• Batched at field-mixing stations or on-site blending units; mixed with monomer and initiator immediately before injection to the target strata. Operators monitor viscosity, shear profile, and crosslink density in real time for field conformance control.

Final product types

• Water shut-off polymer gels for injection wells
• Profile control and selective plugging agents
• Stabilizing agents in fracturing fluid compositions

4. Paper Industry Wet-Strength Resin Manufacture

Paper and specialty packaging producers utilize our crosslinker in cationic polyacrylamide (CPAM) resin synthesis to create permanent wet-strength characteristics in high-value tissue and specialty paper grades. This application requires reliable crosslink formation to achieve strength without excessive migration or extractables, while supporting rapid paper-machine operations under high-throughput conditions.

Industry compliance standards

• FDA 21 CFR 176.170 and 176.180 (Paper and Paperboard in Contact with Aqueous and Fatty Foods)
• EN 13432: Packaging—Requirements for Packaging Recoverable through Composting and Biodegradation
• Food Contact Materials Regulation (EU) No 10/2011
• ISO 14001:2015 Environmental Management System

Typical usage ratio

• 0.1–0.3% based on dry polyacrylamide solids; formulation engineers refine the addition rate for desired crosslink density and end-use wet strength specifications with respect to machine speed and furnish blend.

Downstream process integration

• Blend with acrylamide and cationic monomers before resin polymerization step; main addition at reactor charging stage under controlled agitation, followed by in situ application to pulp furnish during papermaking.

Final product types

• Wet-strength facial tissues
• High-wet-strength food contact papers
• Label base papers and technical filter substrates

5. Cosmetic Hydrogel Network Formation

Personal care formulators integrate our material as a crosslinking agent in transparent, flexible hydrogels—enabling high stability, clarity, and skin adhesion for sheet masks and wound care patches. Cosmetic-grade supply undergoes further purification and microbiological quality checks to support regulatory filings for direct skin contact use across Asian, American, and EU markets.

Industry compliance standards

• EU Regulation (EC) No 1223/2009 on Cosmetic Products
• China National Medical Products Administration (NMPA) Cosmetic Registration
• U.S. FDA 21 CFR Parts 700–740: Cosmetic Product Safety
• ISO 22716:2007 Cosmetic Good Manufacturing Practices (GMP)

Typical usage ratio

• 0.05–0.2% based on total hydrogel mass, with lower levels in leave-on products and higher amounts for peel-off or mask gels. Final ratio determined through pilot compatibility and skin irritation testing.

Downstream process integration

• After combining monomer and functional additives, add the crosslinker under mixing at ambient or cooled temperatures; commence polymerization only when system homogeneity and pH stabilization achieved. Strictly adhere to validated hygiene and allergen control practices during production.

Final product types

• Hydrogel sheet masks
• Facial patch gels for transdermal active delivery
• Cushion gels for wound dressing and blister plasters

6. Electrophoresis Gel Kit Manufacturing

Diagnostic and research kit manufacturers use our crosslinker in ready-to-use precast electrophoresis gels, prioritized for lot-to-lot uniformity and absence of impurities that interfere with sensitive biomolecular analysis. This grade supports high-resolution analysis by meeting stringent QC for non-cross-reactivity and controlled pore architecture.

Industry compliance standards

• ISO 9001:2015 for laboratory diagnostics manufacturing
• ISO 15189:2012 Medical Laboratories – Requirements for Quality and Competence
• U.S. FDA 21 CFR 820: Quality System Regulation for Medical Devices
• Restriction of Hazardous Substances (RoHS) Directive

Typical usage ratio

• Standard 3–5% with acrylamide content in gel kits for analytical separations, adjusted down to 0.8–2% for preparative gels requiring larger pore structures; suppliers specify composition based on primary customer analytes.

Downstream process integration

• Gel solution compounded in closed batch tanks: sequential metering of buffer, acrylamide, and crosslinker; initiate gelation in discrete molds under controlled temperature and humidity. All mixing tanks and molding lines cleaned to prevent cross-contamination with interfering substances.

Final product types

• Precast polyacrylamide gels for protein and nucleic acid electrophoresis
• Single-use gel slabs for DNA ladder separation
• Mini gel cassettes and multi-well analytical formats